1. Technical Field
This invention relates generally to the field of spectroscopy and, more specifically, to surface enhanced Raman spectroscopy (SERS) and fluorescence spectroscopy, and to sample support surfaces for use in such spectroscopy.
2. General Background
Raman scattering is a well known detection method for molecule sensing. Raman spectra can be used to fingerprint molecules of particular interest. Raman spectroscopy can provide important structural information on conformational changes, such as between native and denatured molecules. Raman difference spectroscopy can be used to detect allosteric conformational changes in biomolecules. SERS provides even greater detection sensitivity than conventional Raman spectroscopy. SERS is particularly well suited for the study of biological molecules that have been adsorbed on a metal surface. SERS spectroscopy allows for the detection and analysis of minute quantities of analytes. The large scattering enhancements of SERS permit one to obtain high-quality SERS spectra at sub-monolayer molecular coverage. SERS is sensitive to molecular orientation and to the distance between the molecule of interest and an adjacent metal surface. SERS can be particularly efficient in detecting the conformational state and orientation of molecules since there is generally a preferable orientation of the molecular subunits on a metal surface that can be different for different conformations.
The SERS enhancement mechanism originates in part from the large local electromagnetic fields caused by resonant surface plasmons that can be optically excited at a certain wavelength for metal particles of different shapes or closely spaced groups of particles. For aggregates of interacting particles, which can be structured as fractals, plasmon resonances can be excited in a very broad spectral range. In addition to electromagnetic field enhancement, metal nanostructures and molecules can form charge-transfer complexes that provide further enhancement for SERS. The resulting overall enhancement depends on the particle or aggregate nanostructure morphology. The enhancement can be as high as 105 to 108 for the area-averaged macroscopic signal and as high as 1010 to 1015 within the local resonant nanostructures.
A variety of structures have been found to be appropriate for SERS, including roughened metal electrodes, aggregated films, metal particles of different fixed morphology, and semi-continuous films near the percolation threshold. The effects on the metal films due to deposition rate, mass thickness, and thermal annealing have been previously studied. Some work has been done to engineer optimal nanostructures with a controlled particle shape, such as triangles, nanoshells, and even bow-tie like structures. Regular arrangements have been achieved by nanosphere lithography, electron beam lithography and through metal coating of dielectric spheres. Despite the variety of shapes and sizes available, metal nanostructures with a fixed morphology rarely match different analytes or provide the optimal SERS spectra in all cases due in part to the large differences in analyte sizes. Further, many substrates are not biocompatible, yet it is of great interest to study biomolecules in their native forms with functionality preserved. Biomolecular research often involves several washing procedures to remove non-binding or excess agents. This washing can also remove metal nanoparticles that have medium to low adhesion to the substrate. Thus, efforts continue to find even better metal surface shapes, sizes, and other characteristics providing further enhancement of SERS and other spectra.
A structure of the present invention, which can be used to support a sample for examination by SERS and other spectrometric techniques, comprises a support layer, a metal island layer, and an adhesive layer attaching the metal island layer to the support layer, the adhesive layer allowing movement, and in some instances chemical restructuring, of the metal islands toward increased proximity upon application and drying of an analyte containing solution. This structure is herein referred to as an adaptive metal film to distinguish it from the static metal films of the prior art. The term metal island is being adopted to indicated the discontinuous character of the adaptive metal film. The adhesive layer can be integral with the support layer. The adhesive layer can be a biocompatible material that will permit movement of the metal islands into closer proximity upon exposure to an analyte containing solution, but will securely fix the metal islands stabilized by the analyte with respect to the support layer upon drying of the solution. The adhesive layer is desirably a material that, in areas not contacted by an analyte containing solution, will allow the removal of the metal islands by washing with a suitable buffer solution. A suitable material for the adhesive layer is vacuum deposited silica. Other suitable materials include alumina, titanium oxides, chromium oxides, zinc oxide, and mixtures of one of those with titanium or chromium, e.g., an SiO2—Ti mixture.
The support layer can be any useful material including a dielectric material, such as glass. The support layer can comprise a bulk metal layer. The bulk metal layer can be located between a dielectric support layer and the adhesive layer. The bulk metal layer is desirably fabricated from highly conductive material typically used for optical mirrors and desirably has a mirror like surface. Suitable materials for the bulk metal layer are silver, gold, aluminum, copper coated with sub-layers of titanium or chromium.
The adaptive metal films can be formed on a dielectric substrate under vacuum evaporation with an electron beam or other vacuum evaporator at an at least moderately hard vacuum. The metals that can be used in the adaptive metal films of the present invention include copper, gold, silver, platinum and palladium, but silver is the preferred metal. The adaptive character of the metal films of the present invention is believed to involve a competition of two processes. A solution of a biomolecule, such as a protein, in a buffered saline may etch metal particle surfaces of the adaptive metal films sufficiently to allow movement of the metal particles relative to the underlying adhesive layer, which are subsequently stabilized interaction with an analyte such as a biomolecule. Since the metal island surface tends to be oxidized during shelf time, a metal surface de-oxidation is also involved in the process of the metal island restructuring. The buffered saline is believed to enhance the stabilization of the metal particles on surfaces of the analyte that may be most suitable for interaction by charge-transfer complexing or other mechanisms. This analyte directed movement of the metal islands leads to significantly enhanced spectral signals particularly with SERS. The optimal proximity is achieved if about a monolayer of an analyte is situated between the stabilized metal particles.
Thus, one aspect of the present invention is a method for preparing an analyte biomolecular sample for collection of spectra data including the steps of depositing the sample in a suitable solution on an adaptive metal film, and allowing the sample to move the metal islands of the film into spectral enhancing proximity during drying of the sample. The metal islands of the adaptive metal film can be considered as initially only modestly bonded to the adhesive layer. Subsequent to exposure to a suitably buffered solution of a analyte of interest, the metal islands that couple to the analyte become more tightly bonded to the adhesive layer so that after drying, any subsequent rinsing by a buffer capable of releasing the nonreacted metal islands for the adhesive layer is unable to release the analyte coupled islands from the adhesive layer. A mixture of an analyte with another molecule can be used to stabilize the metal particle surface. Suitable molecules are polymers like polyvinylpyrrolidone (PVP) that act as stabilizations agents along with the analyte and provide a relatively weak SERS signal. In such a mixture, the concentration of the analyte can be much lower than needed to perform surface restructuring and stabilization.
The adaptive metal films of the present invention can be fabricated to have a range of evaporation parameters that allow for fine rearrangement of their local structure when exposed to various biomolecular solutions. By selecting a suitable adaptive metal film, the adsorbed biomolecules may experience little if any significant changes in conformation during deposition and drying, thus enabling the study of such biomolecules in their natural state. Further the metal-analyte combinations that result from the use of the adaptive metal films of the present invention resist washing and provide enhanced spectral response. Thus, through the use of the adaptive metal films of the present invention one is able to study biomolecules in close association with metal particles naturally located in structures that improve SERS, resist washing, and preserve biomolecule conformation. This is particularly useful when studying large proteins and protein microarrays.
While the following discussion will present a number of examples of the use of the adaptive metal films of the present invention, the examples are not intended to be limiting in any way, but merely exemplary of the range of utility of the present invention.
a is a schematic side elevation of an adaptive metal film of the present invention.
b is a schematic side elevation of another adaptive metal film of the present invention.
a is a schematic side elevation of an adaptive metal film of the present invention, which could be an adaptive metal film of either
b is a schematic view similar to
c is a schematic view similar to
a is a photomicrograph of an adaptive metal film of the present invention.
b is a photomicrograph similar to
a is a photograph of an adaptive metal film of the presentation following deposit and drying of a number of analyte containing droplets.
b is a photograph of the same adaptive metal film subsequent to a post drying rinsing step.
a is a superposition of thirty SERS spectra of the fAb monoclonal antibody on an adaptive metal film of the present invention, fifteen before and fifteen after being incubated with fBAP.
b is a superposition of thirty SERS spectra of the fAb monoclonal antibody on an adaptive metal film of the present invention, fifteen before and fifteen after being incubated with BAP.
a is a superposition of eighteen SERS spectra of fBAP on an adaptive metal film of the present invention, nine before and nine after being incubated with fAb.
b is a plot of the two averages of each of the nine spectra shown in
a is a SERS spectra collected at 568 nm incident laser wavelength for human insulin and insulin lispro on an adaptive metal film of the present invention.
b is a plot of the difference between the SERS spectra shown in
The layered structures of the present invention can be formed on a dielectric substrate such as glass. One structure of an adaptive metal film 10 of the present invention is shown in
The substrate 12 can be a clean glass slide of the type typically used for light microscopy. The glass slide can be cleaned using a number of steps. For example, a glass slide can be washed multiple solvent rinses and then soaked in a piranha (H2O2:3H2SO4) acid bath, rinsed in 18 MΩ deionized water, and dried with pressurized gaseous nitrogen. The cleaned glass slide can then placed in an electron beam evaporator with an initial pressure inside the system of about 10−7 Torr. The glass slide can be covered with a base metal layer as shown in
The addition of a biomolecule of interest to an adaptive metal film 10 of the present invention can be accomplished by initially forming a suitable solution of the biomolecule. For example, a 0.5 μM solution of an analyte, such as bacterial alkaline phosphatase (BAP), can be prepared. Aliquots of about 2 μL of the analyte solution can be deposited, either manually or by a suitable dispensing head, on the adaptive metal film 10 in separate droplets 20. A solution droplet 20 is schematically shown in
A plan view of an adaptive metal film 10 subsequent to the rinsing step is shown in
a is a plan view on a much larger scale than
Light impinging on a semicontinuous metal film will undergo transmission, reflection, or absorption, with a small percentage, typically less than 5%, experiencing scattering. By measuring the intensity of light in each of these processes at different frequencies, one can judge whether the film structure supports resonant plasmon modes. At the frequencies where resonances occur, absorption increases.
While the FE SEM images of
The elemental species on a sample surface can be analyzed using X-ray photoelectron spectroscopy (XPS). This technique is capable of probing roughly 10 nm into a sample surface, which is the approximate thickness of the metal island layer of an adaptive metal film of the present invention (and any biomolecules deposited onto the film surface). By measuring the kinetic energy of the photoelectrons at a given photon energy (typically 1486.6 eV), one can detect the binding energy spectrum. The binding energy peaks are characteristic for each element, while the peak areas can be used to determine the relative composition of the sample surface. The shape of each peak and the binding energy can be slightly altered by the chemical state of the emitting atom. Hence, XPS can provide chemical bonding information as well.
The adaptive metal films 10 of the present invention are suitable for use in a number of testing situations. For example, the adaptive metal films of the present invention can be used to probe antigen-antibody binding. This can be accomplished by depositing and immobilizing a monoclonal antibody or a corresponding antigen on an adaptive metal film. Typically, 2 μL of 0.5 μM antibody solution form a spot of about 2 mm diameter after drying overnight. The non-adherent metal particles of the adaptive metal film are then removed by washing with a buffered solution and deionized water to reveal immobilized protein-adapted aggregates representing antibody (or antigen) in a small array. The specific proteins used in the development of the process included the anti-FLAG M2 monoclonal antibody (fAb) and the bacterial alkaline phosphatase/C-terminal FLAG-peptide fusion (fBAP). Proteins for control experiments included the bacterial alkaline phosphatase (BAP) without the FLAG peptide, which was generated by enterokinase cleavage. Subsequent incubation of the protein-adapted aggregates With antigen (or antibody) was conducted. The nonspecifically-bound material was removed by washing with a standard buffer solution for Western blotting (TBS/Tween-20) followed by rinsing five times with deionized water. SERS spectra of the immobilized fAb (or fBAP) were compared before and after reaction with the cognate antigen (or antibody) partner.
The SERS spectra can be collected with a variety of known instruments. The spectra recorded herein were collected with a four-wavelength Raman system that included an Ar/Kr ion laser (from Melles Griot), a laser band-path holographic filter (to reject plasma lines) and two Super-Notch Plus filters (from Kaiser Optical Systems) to reject Rayleigh scattering, focusing and collection lenses, an Acton Research 300i monochromator with a grating of 1200 grooves/mm, and a nitrogen-cooled CCD (1340×400 pixels from Roper Scientific). SERS spectra were typically collected using a laser beam excitation wavelength of 568.2 nm with normal incidence and 45° scattering. An objective lens (f/1.6) provided a collection area of about 180 μm2. Collected light was delivered to the spectrometer via a fiber bundle. The spectral resolution was about 3 cm−1.
The immobilized fAb/metal clusters that result from deposition and drying of the fAb on an adaptive metal film yielded reproducible SERS results, and representative spectra are shown in
Further validation of the detectability of such interactions is observed by first depositing and drying a fBAP solution (0.5 μM in TBS buffer) on an adaptive metal film 10 of the present invention. The washed and rinsed fBAP surface was then incubated with fAb at a concentration of about 4 nM. The results of the SERS measurements before and after the incubation are shown in
The nanostructured adaptive metal films of the present invention can also be used with other detection methods such as chemiluminescence and fluorescence to study the same deposit. For example, alternative detection methods can be used to validate the integrity of the fAb-fBAP binding events on the adaptive metal film, and to assess the utility of the protein-adapted clusters for applications in protein binding assays. For detection by chemiluminescence, fAb, fBAP and BAP were each deposited on an adaptive metal substrate at equal concentrations and sequentially reacted with fAb and HRP-conjugated anti-mouse IgG secondary antibody. The specificity of the reactions shown in
A study of insulin and insulin analogs demonstrates the discrimination capacity the adaptive metal substrates of the present invention. It is well known that insulin is composed of two peptide chains referred to as the A and B chains. The two chains are linked together by two disulfide bonds, and an additional disulfide is formed within the A chain. The A chain consists of 21 amino acids, while the B chain consists of 30 amino acids. Insulin monomer is the active form of the hormone. Insulin exists as a monomer in solution at neutral pH and at physiological concentrations (about 1 ng/mL). Hydrogen bonding between C-termini of the B chains in solution results in a tendency to form dimers of human insulin molecules. Anti-parallel-pleated-sheet interactions are involved in the formation of insulin dimers. Additionally, in the presence of zinc ions, insulin dimers associate into hexamers. These interactions have very important clinical effects because monomers and dimers readily diffuse into blood, whereas hexamers diffuse very poorly. As a result, absorption of insulin preparations containing a high proportion of hexamers is strongly delayed.
This has stimulated development of a number of recombinant insulin analogs. The first of these molecules, which is called insulin lispro, is engineered so that lysine and proline residues on the C-terminal end of the B chain are interchanged in their positions. Thus lispro is Lys(B28) Pro(B29) human insulin analog, having the identical chemical composition and molecular weight with normal human insulin. It is very hard or impossible to distinguish the two insulins with convention protein analysis techniques, such as mass spectroscopy and chromatographic separation. The lispro modification minimizes the tendency to form dimmers and hexamers but does not alter receptor binding. As a result, insulin lispro is a rapidly acting, parenteral blood glucose-lowering agent.
The comparative study of human insulin and lispro was conducted on adaptive metal films of the present invention previously described in connection with
The observed difference can be attributed to conformational differences in the two biomolecules. The solutions employed in the development of the spectra shown in
The SERS signals for materials deposited on the adaptive metal films of the present invention can be materially increased by including a bulk metal layer 13 that is situated between the dielectric substrate 12 and the adhesive layer 14 as shown in
The nanostructured adaptive metal films of the present invention exhibit clear advantages over static structure SERS substrates. The adaptive feature of the films of the present invention appears to produce cavity sites created by two or more metal particles or islands, the cavity sites being filled with, and at least to some extent defined by, the analyte of interest. The adaptive metal films of the present invention experience fine restructuring under analyte solution deposition such that the conformation and functionality of biomolecular analytes are largely preserved.
The foregoing detailed description should be regarded as illustrative rather than limiting, and the following claims, including all equivalents, are intended to define the spirit and scope of this invention.
The present application is related to and claims all possible benefits of U.S. provisional application 60/555,944 filed Mar. 24, 2004; 60/569,760 filed May 10, 2004; and 60/628,061 filed Nov. 15, 2004.
Number | Date | Country | |
---|---|---|---|
60555944 | Mar 2004 | US | |
60569760 | May 2004 | US | |
60628061 | Nov 2004 | US |